Causeway Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $50.8M | Buy |
|
|||||
|
2025
Q2 | $42.5M | Sell |
|
|||||
|
2025
Q1 | $42.9M | Buy |
|
|||||
|
2024
Q4 | $36.4M | Buy |
|
|||||
|
2024
Q3 | $36.7M | Buy |
|
|||||
|
2024
Q2 | $29M | Buy |
|
|||||
|
2024
Q1 | $31.6M | Sell |
|
|||||
|
2023
Q4 | $29.5M | Buy |
|
|||||
|
2023
Q3 | $20.5M | Buy |
|
|||||
|
2023
Q2 | $14.2M | Buy |
|
|||||
|
2023
Q1 | $11.4M | Buy |
|
|||||
|
2022
Q4 | $8.33M | Buy |
|
|||||
|
2022
Q3 | $5.4M | Sell |
|
|||||
|
2022
Q2 | $11.2M | Sell |
|
|||||
|
2022
Q1 | $11.3M | Buy |
|
|||||
|
2021
Q4 | $7.87M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $59K | Sell |
|
|||||
|
2018
Q4 | $10.9M | Sell |
|
|||||
|
2018
Q3 | $15.7M | Sell |
|
|||||
|
2018
Q2 | $17.3M | Sell |
|
|||||
|
2018
Q1 | $36M | Buy |
|
|||||
|
2017
Q4 | $22.4M | Buy |
|
|||||
|
2017
Q3 | $22.4M | Buy |
|
|||||
|
2017
Q2 | $18.3M | Buy |
|
|||||
|
2017
Q1 | $13.3M | Buy |
|
|||||
|
2016
Q4 | $11M | Sell |
|
|||||
|
2016
Q3 | $14.1M | Sell |
|
|||||
|
2016
Q2 | $14.3M | Sell |
|
|||||
|
2016
Q1 | $19.3M | Sell |
|
|||||
|
2015
Q4 | $20.9M | Sell |
|
|||||
|
2015
Q3 | $23.3M | Buy |
|
|||||
|
2015
Q2 | $21.1M | Buy |
|
|||||
|
2015
Q1 | $20.3M | Buy |
|